EUVIMEDEUVIMED entdecken
Crossref

Blood Metabolites as Biomarkers and Metabolism Mechanism Studies of Hemorrhagic Fever With Renal Syndrome

Yanying Dong iD, Jingjing Yin, Jiaojiao Wu iD, Hua Zhang, Yan Li, Ruihong Qin, Jian Shi, Qi Dang, Ming Xie, Peixing Xu iD

Journal of Medical Virology · 2026

DOI: 10.1002/jmv.71187 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Yanying Dong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Transfusion Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Biomarkers, Hemorrhagic Fever with Renal Syndrome, Metabolome. Die Arbeit nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Research and Development Program of Shaanxi Province, Xi'an Jiaotong University Medical "Basic-to-Clinical" Integrated Innovation Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hemorrhagic Fever with Renal Syndrome (HFRS) is a potentially life‐threatening hantavirus zoonosis endemic to East Asia, especially China, featuring fever, hemorrhage, and acute renal injury. This study aimed to identify serum metabolic biomarkers for HFRS staging and explore impaired metabolic pathways. We performed untargeted serum metabolomic profiling via ultra‐performance liquid chromatography tandem mass spectrometry (UPLC‐MS/MS) on samples from acute‐phase, convalescent HFRS patients, and healthy controls. Data from untargeted metabolomics showed that 168 metabolites were significantly altered in HFRS patients. Among these, 14 metabolites could distinguish the pairwise group comparisons (patient/NC, AP/CP, AP/NC, and CP/NC), with univariate AUCs ranging from 0.7556 to 1.000; a LASSO‐based combined model yielded leave‐one‐out cross‐validated (LOOCV) AUCs of 1.000, 0.993, and 0.840 for AP/NC, CP/NC, and AP/CP, respectively, indicating their potential to distinguish disease stages. Pathway analysis revealed significant perturbations in arginine biosynthesis, ascorbate and aldarate metabolism, and taurine and hypotaurine metabolism, indicating the importance in the metabolic dysfunction of HFRS. Metabolites within the arginine biosynthesis pathway were markedly altered and effectively differentiated acute‐phase HFRS from healthy controls, suggesting their role in predicting acute disease status. Distinct serum metabolite abundance shifts can stratify HFRS stages. The 14 metabolites and their combined panels discriminated disease stages with univariate AUCs of 0.756–1.000 and leave‐one‐out cross‐validated AUCs of 0.840–1.000, supporting serum metabolites as candidate biomarkers for distinguishing HFRS stages and providing a basis for targeted metabolomics studies of HFRS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersHemorrhagic Fever with Renal SyndromeMetabolomeHumansTandem Mass SpectrometryMetabolomicsFemaleMaleAdultChromatography, High Pressure LiquidMetabolic Networks and PathwaysMiddle AgedChina

Stichwörter der Autor:innen

diagnostic biomarkerhemorrhagic fever with renal syndromemetabolic pathwayultra‐performance liquid chromatography tandem mass spectrometry (UPLC‐MS/MS)

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Transfusion Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Clinical Laboratory, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Department of Pathogenic Biology and Immunology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.
  • Clinical Laboratory, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.

ORCID-Profile: Yanying Dong, Jiaojiao Wu, Peixing Xu

Förderung

  • National Natural Science Foundation of China
  • Key Research and Development Program of Shaanxi Province
  • Xi'an Jiaotong University Medical "Basic-to-Clinical" Integrated Innovation Project

Zitieren

APA

Dong, Y., Yin, J., Wu, J., Zhang, H., Li, Y., Qin, R., Shi, J., Dang, Q., Xie, M., & Xu, P. (2026). Blood Metabolites as Biomarkers and Metabolism Mechanism Studies of Hemorrhagic Fever With Renal Syndrome. Journal of Medical Virology. https://doi.org/10.1002/jmv.71187

Vancouver

Dong Y, Yin J, Wu J, Zhang H, Li Y, Qin R, et al. Blood Metabolites as Biomarkers and Metabolism Mechanism Studies of Hemorrhagic Fever With Renal Syndrome. Journal of Medical Virology. 2026. doi:10.1002/jmv.71187

BibTeX
@article{Dong2026,
  author = {Dong, Yanying and Yin, Jingjing and Wu, Jiaojiao and Zhang, Hua and Li, Yan and Qin, Ruihong and Shi, Jian and Dang, Qi and Xie, Ming and Xu, Peixing},
  title = {Blood Metabolites as Biomarkers and Metabolism Mechanism Studies of Hemorrhagic Fever With Renal Syndrome},
  journal = {Journal of Medical Virology},
  year = {2026},
  doi = {10.1002/jmv.71187}
}
Kostenlos starten →